Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Braz. j. med. biol. res ; 46(9): 746-751, 19/set. 2013. graf
Article Dans Anglais | LILACS | ID: lil-686569

Résumé

Macrophage migration inhibitory factor (MIF), a pleiotropic cytokine, plays an important role in the pathogenesis of atrial fibrillation; however, the upstream regulation of MIF in atrial myocytes remains unclear. In the present study, we investigated whether and how MIF is regulated in response to the renin-angiotensin system and oxidative stress in atrium myocytes (HL-1 cells). MIF protein and mRNA levels in HL-1 cells were assayed using immunofluorescence, real-time PCR, and Western blot. The result indicated that MIF was expressed in the cytoplasm of HL-1 cells. Hydrogen peroxide (H2O2), but not angiotensin II, stimulated MIF expression in HL-1 cells. H2O2-induced MIF protein and gene levels increased in a dose-dependent manner and were completely abolished in the presence of catalase. H2O2-induced MIF production was completely inhibited by tyrosine kinase inhibitors genistein and PP1, as well as by protein kinase C (PKC) inhibitor GF109203X, suggesting that redox-sensitive MIF production is mediated through tyrosine kinase and PKC-dependent mechanisms in HL-1 cells. These results suggest that MIF is upregulated by HL-1 cells in response to redox stress, probably by the activation of Src and PKC.


Sujets)
Animaux , Souris , Peroxyde d'hydrogène/pharmacologie , Intramolecular oxidoreductases/effets des médicaments et des substances chimiques , Facteurs inhibiteurs de la migration des macrophages/effets des médicaments et des substances chimiques , Myocytes cardiaques/métabolisme , Oxydants/pharmacologie , Protéine kinase C/métabolisme , src-Family kinases/métabolisme , Angiotensine-II/métabolisme , Technique de Western , Lignée cellulaire , Immunohistochimie , Intramolecular oxidoreductases/génétique , Microscopie confocale , Facteurs inhibiteurs de la migration des macrophages/génétique , Stress oxydatif/physiologie , Inhibiteurs de protéines kinases/pharmacologie , Réaction de polymérisation en chaine en temps réel , Système rénine-angiotensine/physiologie
2.
Braz. j. med. biol. res ; 44(2): 91-99, Feb. 2011. ilus, tab
Article Dans Anglais | LILACS | ID: lil-573653

Résumé

Searching for effective Smad3 gene-based gene therapies for hepatic fibrosis, we constructed siRNA expression plasmids targeting the rat Smad3 gene and then delivered these plasmids into hepatic stellate cells (HSCs). The effect of siRNAs on the mRNA levels of Smad2, Smad3, Smad4, and collagens I-α1, III-α1 and IV-α1 (Colα1, Col3α1, Col4α1, respectively) was determined by RT-PCR. Eighty adult male Sprague-Dawley rats were randomly divided into three groups. Twice a week for 8 weeks, the untreated hepatic fibrosis model (N = 30) and the treated group (N = 20) were injected subcutaneously with 40 percent (v/v) carbon tetrachloride (CCl4)-olive oil (3 mL/kg), and the normal control group (N = 30) was injected with olive oil (3 mL/kg). In the 4th week, the treated rats were injected subcutaneously with liposome-encapsulated plasmids (150 µg/kg) into the right liver lobe under general anesthesia once every 2 weeks, and the untreated rats were injected with the same volume of buffer. At the end of the 6th and 8th weeks, liver tissue and sera were collected. Pathological changes were assessed by a semi-quantitative scoring system (SSS), and a radioimmunoassay was used to establish a serum liver fibrosis index (type III procollagen, type IV collagen, laminin, and hyaluronic acid). The mRNA expression levels of the above cited genes were reduced in the HSCs transfected with the siRNA expression plasmids. Moreover, in the treated group, fibrosis evaluated by the SSS was significantly reduced (P < 0.05) and the serum indices were greatly improved (P < 0.01). These results suggest that Smad3 siRNA expression plasmids have an anti-fibrotic effect.


Sujets)
Animaux , Mâle , Rats , Régulation négative/génétique , Cellules étoilées du foie/métabolisme , Cirrhose expérimentale/métabolisme , ARN messager/génétique , Petit ARN interférent/usage thérapeutique , /métabolisme , Tétrachloro-méthane , Collagène/métabolisme , Liposomes , Cirrhose expérimentale/induit chimiquement , Cirrhose expérimentale/génétique , Cirrhose expérimentale/anatomopathologie , Plasmides , Dosage radioimmunologique , Répartition aléatoire , Rat Sprague-Dawley , RT-PCR , Interférence par ARN , ARN messager/métabolisme , Indice de gravité de la maladie , /génétique , Transfection , Facteur de croissance transformant bêta-1/génétique , Facteur de croissance transformant bêta-1/métabolisme
SÉLECTION CITATIONS
Détails de la recherche